This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A cultural shift emphasizing the importance of compassion in patient care needs to occur to improve outcomes of our patients and our job satisfaction; as such, compassion should be part of our training and CME. Compassion in not simply innate; like any behaviour, it can be learned through deliberate practice.
The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Attendees will gain valuable clinical insights and explore cutting-edge therapies aimed at improving overall health outcomes. “Dr.
Neha Agarwal, PhD, Clinical Director at Cardiometabolic Health Congress , Informa Connect, recently presented significant findings at the 84th American Diabetes Association (ADA) Scientific Sessions. The Diabetes Track will feature: “Precision Medicine in Diabetes” by Jose C.
The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. After the reception, many attendees enjoyed dinner at the PME (Non-CME) Dinner Symposium or ventured to one of Boston’s trendy Back Bay eateries. Ballantyne, MD , explored Lipoprotein(a).
As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.
Addressing Disparities and Expanding Access Sessions highlighted the importance of improving cardiovascular health in women and underrepresented minorities, emphasizing the need for diverse healthcare providers to build trust and improve outcomes. Earn 14 CME credits anytime on any device. Read the published study.
Our expert faculty at CMHC delve into critical issues, offering insights on managing very low LDL-C, addressing concerns with statins and new-onset diabetes, and exploring the residual ASCVD risk beyond LDL-C, among other essential topics, in the CMHC Lipid Management Hub.
With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. cardiometabolic health CME/CE conference: the 19th Annual CMHC. In the U.S.,
November is National Diabetes Month , and with the increasing overlap between type 2 diabetes (T2D) and metabolic dysfunction-associated steatohepatitis (MASH) , it’s critical to focus on integrating liver health into the management of cardiometabolic patients.
For healthcare providers, adopting an integrated, patient-centered approach is important for better outcomes. Regular assessment of eGFR and UACR, particularly in high-risk populations such as those with diabetes or hypertension, provides crucial insights into patient health. PURCHASE THE 19TH ANNUAL CMHC ON DEMAND
GLP-1 receptor agonists not only improve metabolic outcomes but also provide cardiovascular and renal benefits, making them a cornerstone of comprehensive MASH treatment. Despite these positive outcomes, bariatric surgery is often underutilized and should be considered earlier in the treatment process for eligible patients.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content